Symbol not found
NASDAQ:MDXG 00:00AM GMT
Earnings Announcements
Mimedx Announces Second Quarter 2022 Operating And Financial Results
Published: 08/02/2022 21:54 GMT
Mimedx Group Inc (MDXG) - Mimedx Announces Second Quarter 2022 Operating and Financial Results.
Q2 Sales Fell 1.9 Percent to $66.9 Million.
Reaffirms 2022 Revenue Growth Outlook of 11% to 14% in Continuing Portfolio of Products.
Qtrly Loss per Share $0.11.
Q2 Sales Fell 1.9 Percent to $66.9 Million.
Reaffirms 2022 Revenue Growth Outlook of 11% to 14% in Continuing Portfolio of Products.
Qtrly Loss per Share $0.11.
Revenue is expected to be $71.7 Million
Adjusted EPS is expected to be -$0.04
Next Quarter Revenue Guidance is expected to be $77.31 Million
Next Quarter EPS Guidance is expected to be -$0.02
More details on our Analysts Page.
Adjusted EPS is expected to be -$0.04
Next Quarter Revenue Guidance is expected to be $77.31 Million
Next Quarter EPS Guidance is expected to be -$0.02
More details on our Analysts Page.